Question 1

Does UBS Group own CLGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 1,035 shares of CLGN (CollPlant Biotechnologies), worth $361.

Question 2

How many shares of CLGN does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 1,035 shares of CLGN (CollPlant Biotechnologies).

Question 3

What is UBS Group's CLGN position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's CLGN position is worth $361.

Question 4

Is UBS Group buying or selling CLGN?

Accepted Answer

In Q2 2026, UBS Group increased its CLGN position from 95 to 1,035 shares.

Question 5

When did UBS Group first buy CLGN?

Accepted Answer

UBS Group first reported CLGN in its Q2 2021 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1,035	+989.5%	$361	0.0%	$0.35	12
2026-Q1	New	95	—	$51	0.0%	$5.36	17
2025-Q2	Exited	0	-100.0%	$0	0.0%	$13.60	0
2025-Q1	Increased	24,074	+8.4%	$62,111	0.0%	$25.80	15
2024-Q4	Increased	22,208	+85.9%	$79,949	0.0%	$36.00	23
2024-Q3	Increased	11,947	+67.3%	$59,317	0.0%	$4.93	21